Macrogenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.20

-0.09 (-3.93%)

As of Nov 14, 10:39 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 64%

Hold 5 36%

Sell 0 0%

Price Target

Analyst Price Target +1,893.2% upside

Low Target $27.62

Average Target $43.85

High Target $64.74

Current Price $2.20

Current
$2.20

Target
$43.85

$27.62 $43.85 avg $64.74

Scenario Analysis

Bear Case

$27.62

1,155.5%

Low target

Base Case

$43.85

+1,893.2%

Avg target

Bull Case

$64.74

+2,842.7%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$5.08

-56.7% from high

52-Week Low

$1.32

+66.7% from low

Target vs 52W High

$43.85

+763.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%